Expert Interview
A second look: Discussing Gossamer Bio's Phase 3 PROSERA Study in advance of the topline data in February evaluating seralutinib in PAH
Ticker(s): GOSSInstitution: John Hopkins
- Assistant Professor of Medicine at John Hopkins, pulmonology. He is the Director of the Tobacco Treatment and Cancer Screening Clinic, Maryland’s largest clinic devoted to smoking cessation and cancer screenings.
- Clinical focus on the diagnosis and treatment of obstructive lung disease, tobacco cessation, and critically ill patients
- Has studied extensively population health and health equity strategies in order to implement community-level initiatives to help overcome health disparities.
What are your preferred treatments for PAH?
Added By: wilson_adminLikelihood of topline success for PROSERA?
Added By: wilson_adminHow would you envision using seralutinib if approved?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
